APA (7th ed.) Citation

Takasu, M., Tanitame, K., Baba, Y., Akiyama, Y., Tamura, T., Kondo, S., . . . Awai, K. (2021). Does chemical shift imaging offer a biomarker for the diagnosis and assessment of disease severity in multiple myeloma?: A cross-sectional study. Medicine (Baltimore), 100(6), e24358. https://doi.org/10.1097/MD.0000000000024358

Chicago Style (17th ed.) Citation

Takasu, Miyuki, Keizo Tanitame, Yasutaka Baba, Yuji Akiyama, Takayuki Tamura, Shota Kondo, Shogo Maeda, Akira Sakai, and Kazuo Awai. "Does Chemical Shift Imaging Offer a Biomarker for the Diagnosis and Assessment of Disease Severity in Multiple Myeloma?: A Cross-sectional Study." Medicine (Baltimore) 100, no. 6 (2021): e24358. https://doi.org/10.1097/MD.0000000000024358.

MLA (9th ed.) Citation

Takasu, Miyuki, et al. "Does Chemical Shift Imaging Offer a Biomarker for the Diagnosis and Assessment of Disease Severity in Multiple Myeloma?: A Cross-sectional Study." Medicine (Baltimore), vol. 100, no. 6, 2021, p. e24358, https://doi.org/10.1097/MD.0000000000024358.